These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25731696)

  • 1. Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism.
    Menzfeld C; John M; van Rossum D; Regen T; Scheffel J; Janova H; Götz A; Ribes S; Nau R; Borisch A; Boutin P; Neumann K; Bremes V; Wienands J; Reichardt HM; Lühder F; Tischner D; Waetzig V; Herdegen T; Teismann P; Greig I; Müller M; Pukrop T; Mildner A; Kettenmann H; Brück W; Prinz M; Rotshenker S; Weber MS; Hanisch UK
    Glia; 2015 Jun; 63(6):1083-99. PubMed ID: 25731696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
    Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3
    Ahmad SF; Ansari MA; Nadeem A; Zoheir KM; Bakheet SA; Al-Shabanah OA; Al Rikabi AC; Attia SM
    Mol Immunol; 2016 Oct; 78():65-78. PubMed ID: 27608299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM
    Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine kinase inhibitor AG126 restores receptor signaling and blocks release functions in activated microglia (brain macrophages) by preventing a chronic rise in the intracellular calcium level.
    Kann O; Hoffmann A; Schumann RR; Weber JR; Kettenmann H; Hanisch UK
    J Neurochem; 2004 Aug; 90(3):513-25. PubMed ID: 15255929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma.
    Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
    Neuropharmacology; 2007 Jun; 52(7):1454-71. PubMed ID: 17418876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation.
    Cuzzocrea S; McDonald MC; Mazzon E; Siriwardena D; Calabrò G; Britti D; Mazzullo G; De Sarro A; Caputi AP; Thiemermann C
    Am J Pathol; 2000 Jul; 157(1):145-58. PubMed ID: 10880385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors.
    Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG
    Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
    Parodi B; Rossi S; Morando S; Cordano C; Bragoni A; Motta C; Usai C; Wipke BT; Scannevin RH; Mancardi GL; Centonze D; Kerlero de Rosbo N; Uccelli A
    Acta Neuropathol; 2015 Aug; 130(2):279-95. PubMed ID: 25920452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
    Bright JJ; Du C; Sriram S
    J Immunol; 1999 May; 162(10):6255-62. PubMed ID: 10229872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis.
    Balachandra S; Genovese T; Mazzon E; Di Paola R; Thiemerman C; Siriwardena AK; Cuzzocrea S
    Surgery; 2005 Nov; 138(5):913-23. PubMed ID: 16291393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
    Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
    J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair.
    Geladaris A; Torke S; Saberi D; Alankus YB; Streit F; Zechel S; Stadelmann-Nessler C; Fischer A; Boschert U; Häusler D; Weber MS
    Acta Neuropathol; 2024 Apr; 147(1):75. PubMed ID: 38656399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
    Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
    J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
    Kuo PC; Brown DA; Scofield BA; Yu IC; Chang FL; Wang PY; Yen JH
    Brain Behav Immun; 2016 Oct; 57():173-186. PubMed ID: 27013356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
    Wei J; Zheng M; Liang P; Wei Y; Yin X; Tang Y; Xue Y
    Neurobiol Dis; 2013 Aug; 56():59-65. PubMed ID: 23619428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556.
    Brenner T; Poradosu E; Soffer D; Sicsic C; Gazit A; Levitzki A
    Exp Neurol; 1998 Dec; 154(2):489-98. PubMed ID: 9878184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.
    Xu D; Kim Y; Postelnek J; Vu MD; Hu DQ; Liao C; Bradshaw M; Hsu J; Zhang J; Pashine A; Srinivasan D; Woods J; Levin A; O'Mahony A; Owens TD; Lou Y; Hill RJ; Narula S; DeMartino J; Fine JS
    J Pharmacol Exp Ther; 2012 Apr; 341(1):90-103. PubMed ID: 22228807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.